tiprankstipranks
Trending News
More News >

Cannara Biotech Boasts Strong Q2 Growth

Cannara Biotech Boasts Strong Q2 Growth

Cannara Biotech, Inc. (TSE:LOVE) has released an update.

Confident Investing Starts Here:

Cannara Biotech Inc. has reported a significant increase in financial results for Q2 2024, with net revenue rising 51% to $19.7 million and gross profit up by 77.2% to $7.1 million compared to the same quarter last year. The company has also achieved its twelfth consecutive quarter of positive Adjusted EBITDA, reaching $3.5 million. These results underscore Cannara’s ongoing growth and market expansion, as it advances towards becoming a leading cannabis producer in Canada.

For further insights into TSE:LOVE stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App